Related Experiment Video
Updated: Jul 22, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
Ben Mulhearn1,2, Jessica Ellis1,2, Sarah Skeoch1,2
1Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, BA1 3NG, UK.
Insights
Giant cell arteritis (GCA) diagnoses significantly increased during the COVID-19 pandemic. A 40-45 day lag suggests SARS-CoV-2 may trigger GCA, prompting further research into this viral aetiology.
Area of Science:
- Rheumatology
- Infectious Diseases
- Epidemiology
Background:
- Giant cell arteritis (GCA) diagnosis rates rose at a UK hospital following the initial COVID-19 wave.
- This observation supports the hypothesis that viral infections may cause GCA.
- Understanding GCA's causes can improve diagnosis and patient outcomes.
Purpose of the Study:
- To estimate GCA incidence in Bath during the COVID-19 pandemic (2020-2021).
- To compare GCA incidence with pre-pandemic data (2015-2019).
- To evaluate the temporal link between COVID-19 and GCA diagnoses.
Main Methods:
- Calculated annual GCA incidence rates from 2015-2021.
- Estimated local COVID-19 prevalence using hospital bed occupancy.
- Employed Poisson statistics and Granger causality to analyze relationships.
Main Results:
- GCA diagnoses increased significantly in 2020 (60 cases) versus 2019 (28 cases).
- Peaks in COVID-19 hospitalizations correlated with GCA diagnosis peaks.
- Granger causality revealed a significant 40-45 day lag between COVID-19 prevalence and GCA incidence.
Conclusions:
- GCA incidence in Bath rose significantly in 2020-2021 compared to 2015-2019.
- A 40-45 day lag suggests COVID-19 may precipitate GCA.
- Further research is ongoing to confirm the causal link between SARS-CoV-2 and GCA.
Background:
Following the first wave of the COVID-19 pandemic, it was observed that giant cell arteritis (GCA) diagnoses increased at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath, UK. This finding may support the viral aetiology hypothesis of GCA. Better understanding of the causes of GCA may help improve diagnostic and treatment strategies leading to better outcomes for patients.
Objectives:
The study aims to estimate the local incidence of GCA during the early COVID-19 pandemic (2020-2021) and compare it to pre-pandemic (2015-2019) data. This study will also evaluate the temporal relationship between COVID-19 infections and GCA diagnoses.
Methods:
Annual incidence rates of GCA were calculated between 2015 and 2021. Local COVID-19 prevalence was estimated by measuring the number of hospital beds taken up by COVID-19 positive patients. Poisson statistics were used to compare the annual mean incidence of GCA between 2019 and 2020, and Granger causality tested the temporal relationship between COVID-19 prevalence and GCA incidence.
Results:
There were 60 (95% confidence interval [CI] 46-77) GCA diagnoses made in 2020 compared to 28 (CI 19-41) in 2019 (P = 0.016). Peaks in the number of COVID-19 inpatients correlated with peaks in GCA diagnoses. Granger causality testing found a statistically significant association between these peaks with a lag period of 40-45 days.
Conclusion:
The incidence of GCA in Bath was significantly increased in 2020 and 2021 compared to 2015-2019. The lag period between peaks was 40-45 days, suggesting that the COVID-19 virus may be a precipitating factor for GCA. More work is currently underway to interrogate the causal relationship between these two diseases.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Single Nucleotide Polymorphisms-SNPs
Causality in Epidemiology